Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Olga Kondrashova(QIMR Berghofer Medical Research Institute)

Nature Communications

September 24, 2018

10.1038/s41467-018-05564-z

Cited by 288

Related Papers

No related papers found

Powered by citation graph analysis